ARCHIVES

NCI Community Intervention Trial Reports

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Awards New Grants

October 20, 1995

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983